Greenwich Lifesciences shares are trading higher by 30.6% Wednesday afternoon. The company provided an update on the Phase III clinical trial, Flamingo-01.
Gainers
Kalera Public Limited Company (NASDAQ: KAL) jumped 76.9% to close at $0.1610 on Wednesday after gaining 9% on Tuesday. Kalera recently posted a Q3 loss of $0.05 per share.
Potential short squeeze plays gained steam in 2021 and have continued through 2022 with new traders looking for the next huge move.
Here’s a look at the top five short squeeze candidates based on the Fintel short squeeze leaderboard.
Potential short squeeze plays gained steam in 2021 and have continued through 2022 with new traders looking for the next huge move.
Here’s a look at the top five short squeeze candidates for the week of Oct. 3 based on the Fintel short squeeze leaderboard.
Potential short squeeze plays gained steam in 2021 and have continued through 2022 with new traders looking for the next huge move.
Here’s a look at the top five short squeeze candidates for the week of Sept. 19, according to Fintel Data: